Publication details

Průběžná zpráva MEMMAT: Metronomická a cílená antiangiogenní terapie pro děti s recidivujícím/progredujícím meduloblastomem

Title in English MEMMAT Interim Report: Metronomic and targeted antiangiogenic therapy for children with recurrent/progressive medulloblastoma


Year of publication 2020
MU Faculty or unit

Faculty of Medicine

Attached files
Description Clinical Trial MEMMAT, EudraCT number: 2010-023691-33 The clinical trial interim report describes the course and current status of the clinical trial (KH) in a defined period. It includes information on document updates, changes in KH centers and examiners, an overview of previously included/completed subjects of evaluation, and detected protocol violations. It also contains information on investigational medicine (reporting serious adverse events, suspicions of serious (unexpected) adverse events, or new findings in relation to safety and efficacy), new measures taken, and audits performed.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info